Related references
Note: Only part of the references are listed.Candidate gene analysis of 21n22: Support for S100B as a susceptibility gene for bipolar affective disorder x with psychosis
S. Roche et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly
J-C Lambert et al.
MOLECULAR PSYCHIATRY (2007)
Oxidative-antioxidative systems and their relation with serum S100B levels in patients with schizophrenia: Effects of short term antipsychotic treatment
Ash Sarandol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Evidence for a wide extra-astrocytic distribution of S100B in human brain
Johann Steiner et al.
BMC NEUROSCIENCE (2007)
SNPs and haplotypes in the S100B gene reveal association with schizophrenia
JX Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF
M Rothermundt et al.
MOLECULAR PSYCHIATRY (2004)
Glia as a putative target for antidepressant treatments
H Manev et al.
JOURNAL OF AFFECTIVE DISORDERS (2003)
Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology
M Rothermundt et al.
MOLECULAR PSYCHIATRY (2001)